Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Antonelli

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Techniques in Coloproctology|March 9, 2013
Hyperhomocysteinemia in patients with Crohn's diseaseG Casella, E Antonelli, C Di Bella, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2001
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertensionS Fiorucci, E Antonelli, O Morelli, et al.
Techniques in Coloproctology|August 18, 2015
Symptomatic sensorineural hearing loss in patients with ulcerative colitisG Casella, D Corbetta, M Zolezzi, et al.
Gastroenterology|January 29, 2000
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokinesS Fiorucci, L Santucci, E Antonelli, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalphaS Fiorucci, L Santucci, B Federici, et al.
Frontiers in Immunology|March 13, 2026
Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective studyF Russo, N Schettini, G L Scaglione, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Techniques in Coloproctology|March 9, 2013
Hyperhomocysteinemia in patients with Crohn's diseaseG Casella, E Antonelli, C Di Bella, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 12, 2001
NCX-1000, a NO-releasing derivative of ursodeoxycholic acid, selectively delivers NO to the liver and protects against development of portal hypertensionS Fiorucci, E Antonelli, O Morelli, et al.
Techniques in Coloproctology|August 18, 2015
Symptomatic sensorineural hearing loss in patients with ulcerative colitisG Casella, D Corbetta, M Zolezzi, et al.
Gastroenterology|January 29, 2000
NO-aspirin protects from T cell-mediated liver injury by inhibiting caspase-dependent processing of Th1-like cytokinesS Fiorucci, L Santucci, E Antonelli, et al.
Alimentary Pharmacology & Therapeutics|April 2, 1999
Nitric oxide-releasing NSAIDs inhibit interleukin-1beta converting enzyme-like cysteine proteases and protect endothelial cells from apoptosis induced by TNFalphaS Fiorucci, L Santucci, B Federici, et al.
Frontiers in Immunology|March 13, 2026
Beneficial effects of upadacitinib on a subgroup of patients with atopic dermatitis and hidradenitis suppurativa: a multicenter, real-world retrospective studyF Russo, N Schettini, G L Scaglione, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|April 12, 2022
Moderate-to-severe atopic dermatitis in adolescents treated with dupilumab: A multicentre Italian real-world experienceL Stingeni, L Bianchi, E Antonelli, et al.
Pageof 3